Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Holen, K. D.
Right arrow Articles by Saltz, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Holen, K. D.
Right arrow Articles by Saltz, L. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?
Journal of Clinical Oncology, Vol 20, Issue 24 (December), 2002: 4673-4678
© 2002 American Society for Clinical Oncology

Clinical Characteristics and Outcomes From an Institutional Series of Acinar Cell Carcinoma of the Pancreas and Related Tumors

By Kyle D. Holen, David S. Klimstra, Amanda Hummer, Mithat Gonen, Kevin Conlon, Murray Brennan, Leonard B. Saltz

From the Memorial Sloan-Kettering Cancer Center, Gastrointestinal Oncology Service, Department of Medicine, Department of Epidemiology and Biostatistics, Department of Pathology, and Gastric and Mixed Tumor Service, Department of Surgery, New York, NY 10021.

Address reprint requests to Leonard B. Saltz, MD, Memorial Sloan-Kettering Cancer Center, Gastrointestinal Oncology Division, Howard Bldg 917, 1275 York Ave, New York, NY 10021; email: saltzl{at}mskcc.org

PURPOSE: Acinar cell carcinoma is a rare tumor of the exocrine pancreas. Clinical features such as prognostic information, survival, and treatment outcomes are unknown. We present the largest retrospective review to date.

PATIENTS AND METHODS: Thirty-nine patients with pathologically confirmed acinar neoplasms of the pancreas were identified between August 1981 and January 2001. Demographic data, tumor characteristics, and treatment information were obtained by chart review. Survival probabilities were estimated by using the Kaplan-Meier method and compared using the log-rank test.

RESULTS: The median survival for all patients was 19 months. On the basis of a univariate analysis, the patients’ stage of disease correlated significantly with survival. The median survival of patients with localized disease was 38 months, versus 14 months for those presenting with metastases (P = 0.03). Patients who could be treated with surgery as first-line therapy had a longer survival time (36 months) compared with those who did not have surgery (14 months). Two of 18 patients who received chemotherapy and three of eight patients who received radiation had a major response.

CONCLUSION: The survival curves suggest a more aggressive cancer than pancreatic endocrine neoplasms but one that is less aggressive than ductal adenocarcinoma of the pancreas. Those patients who present with localized disease have a much better prognosis than those who present with metastases. There is a high recurrence rate after complete surgical resection, suggesting that micrometastases are present even in localized disease and that adjuvant therapies may be indicated. Chemotherapy and radiation afford disappointing results, however, and novel therapies are needed.

Submitted February 1, 2002; accepted July 11, 2002


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Jpn J Clin OncolHome page
Y. Seki, T. Okusaka, M. Ikeda, C. Morizane, and H. Ueno
Four Cases of Pancreatic Acinar Cell Carcinoma Treated with Gemcitabine or S-1 as a Single Agent
Jpn. J. Clin. Oncol., November 1, 2009; 39(11): 751 - 755.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
P Ghaneh, E Costello, and J P Neoptolemos
Biology and management of pancreatic cancer
Postgrad. Med. J., September 1, 2008; 84(995): 478 - 497.
[Full Text] [PDF]


Home page
GutHome page
P. Ghaneh, E. Costello, and J. P Neoptolemos
Biology and management of pancreatic cancer
Gut, August 1, 2007; 56(8): 1134 - 1152.
[Full Text] [PDF]


Home page
JCOHome page
C. Roldo, E. Missiaglia, J. P. Hagan, M. Falconi, P. Capelli, S. Bersani, G. A. Calin, S. Volinia, C.-G. Liu, A. Scarpa, et al.
MicroRNA Expression Abnormalities in Pancreatic Endocrine and Acinar Tumors Are Associated With Distinctive Pathologic Features and Clinical Behavior
J. Clin. Oncol., October 10, 2006; 24(29): 4677 - 4684.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
E. M. Chung, M. D. Travis, and R. M. Conran
From the Archives of the AFIP: Pancreatic Tumors in Children: Radiologic-Pathologic Correlation.
RadioGraphics, July 1, 2006; 26(4): 1211 - 1238.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
S. Tatli, K. J. Mortele, A. D. Levy, J. N. Glickman, P. R. Ros, P. A. Banks, and S. G. Silverman
CT and MRI Features of Pure Acinar Cell Carcinoma of the Pancreas in Adults
Am. J. Roentgenol., February 1, 2005; 184(2): 511 - 519.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2002 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online